HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview

by Geoffrey Férir, Stephanie C. Gordts, Dominique Schols
Published 2014-12-01

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

by Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts
Published 2010-05-01

Labyrinthopeptin A1, a unique lantibiotic peptide with broad-spectrum antiviral (HIV, HSV, influenza, RSV and DENV) activity

by Stephanie Gordts, Leentje Persoons, Sandra Claes, Geoffrey Férir, Mark Brönstrup, Roderich D. Süssmuth, Dominique Schols
Published 2016-05-01

The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.

by Stephanie C Gordts, Geoffrey Férir, Thomas D'huys, Mariya I Petrova, Sarah Lebeer, Robert Snoeck, Graciela Andrei, Dominique Schols
Published 2015-01-01

The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications.

by Geoffrey Férir, Mariya I Petrova, Graciela Andrei, Dana Huskens, Bart Hoorelbeke, Robert Snoeck, Jos Vanderleyden, Jan Balzarini, Stefan Bartoschek, Mark Brönstrup, Roderich D Süssmuth, Dominique Schols
Published 2013-01-01